Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001
-
Shares outstanding
-
17,264,276
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
4,407,963
-
Shares change
-
-10,620,792
-
Total reported value, excl. options
-
$44,695,553
-
Value change
-
-$106,490,199
-
Number of buys
-
2
-
Number of sells
-
26
-
Price
-
$10.14
Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q1 2025
As of 31 Mar 2025 Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,407,963 shares of stock of the company.
Largest 10 holders included Magnetar Financial LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, Calamos Advisors LLC, D. E. Shaw & Co., Inc., MMCAP International Inc. SPC, WOLVERINE ASSET MANAGEMENT LLC, PICTON MAHONEY ASSET MANAGEMENT, Schechter Investment Advisors, LLC, MILLENNIUM MANAGEMENT LLC, and TWO SIGMA INVESTMENTS, LP.
This table shows 43 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.